These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 16563443

  • 1. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
    Löscher W, Dekundy A, Nagel J, Danysz W, Parsons CG, Potschka H.
    Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
    [Abstract] [Full Text] [Related]

  • 2. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
    Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wisłowska A, Płaźnik A, Bespalov AY, Danysz W.
    Eur J Pharmacol; 2005 May 02; 514(1):25-34. PubMed ID: 15878321
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist.
    Shannon HE, Peters SC, Kingston AE.
    Neuropharmacology; 2005 May 02; 49 Suppl 1():188-95. PubMed ID: 16011839
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Bochenski M.
    Eur J Pharmacol; 2008 Nov 19; 598(1-3):57-63. PubMed ID: 18838071
    [Abstract] [Full Text] [Related]

  • 6. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
    Pietraszek M, Gravius A, Schäfer D, Weil T, Trifanova D, Danysz W.
    Neuropharmacology; 2005 Jul 19; 49(1):73-85. PubMed ID: 15992582
    [Abstract] [Full Text] [Related]

  • 7. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L, Bristow LJ, Varney MA, Cosford ND.
    Neuropsychopharmacology; 2004 Nov 19; 29(11):1971-9. PubMed ID: 15305166
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
    Cowen MS, Djouma E, Lawrence AJ.
    J Pharmacol Exp Ther; 2005 Nov 19; 315(2):590-600. PubMed ID: 16014750
    [Abstract] [Full Text] [Related]

  • 12. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task.
    Steckler T, Oliveira AF, Van Dyck C, Van Craenendonck H, Mateus AM, Langlois X, Lesage AS, Prickaerts J.
    Behav Brain Res; 2005 Oct 14; 164(1):52-60. PubMed ID: 16043241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
    Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A.
    Neuropharmacology; 2007 Nov 14; 53(6):741-8. PubMed ID: 17870136
    [Abstract] [Full Text] [Related]

  • 15. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A, Brański P, Szewczyk B, Wierońska JM, Kłak K, Pilc A.
    Pharmacol Biochem Behav; 2005 Aug 14; 81(4):901-6. PubMed ID: 16040106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS.
    Epilepsy Res; 2007 May 14; 74(2-3):147-54. PubMed ID: 17433624
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V, Battaglia G, Copani A, D'Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F.
    J Cereb Blood Flow Metab; 2001 Sep 14; 21(9):1013-33. PubMed ID: 11524608
    [Abstract] [Full Text] [Related]

  • 20. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
    Pałucha A, Brański P, Pilc A.
    Pol J Pharmacol; 2004 Sep 14; 56(6):863-6. PubMed ID: 15662102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.